1Bristol Myers Squibb, Princeton, New Jersey, USA.
2Novartis Pharmaceuticals, Basel, Switzerland.
3Real-World Research, Parexel International, Gothenburg, Sweden.
4Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
5Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
6Child Health Evaluative Sciences, the Hospital for Sick Children and Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
7Novo Nordisk A/S, Global Patient Safety, Søborg, Denmark.
8Eli Lilly and Company, Global Patient Safety, Cork, Ireland.
9RTI Health Solutions, Pharmacoepidemiology and Regulatory Grade RWE, Barcelona, Spain.
10Department of Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany.
11Novartis Pharmaceuticals, East Hanover, New Jersey, USA.
12Rutgers Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Brunswick, New Jersey, USA.